Confibay
← All signals on September 4, 2026
Archive

CLS

BUY
September 4, 2026Horizon stated in the case: 5 trading days

Published once at least 12 trading days had closed after this run.

Summary

Buy starter CLS Celestica Inc around 310-313 while holding above 303.83 (10-day EMA) and 310.77 (Bollinger mid). Small size for ATR 19.6 (~6.3%) and beta 1.46; use 1.5-2x ATR stop, cut on daily close below 303. Add only on settled high-volume close above 327-328 (50-day/200-day). Partial into 327-328 then 346 upper band. Horizon 5 trading days for reclaim/short cover toward 328. Watch Broadcom/hyperscaler capex, tariff/CCS news as hard exits.

The case

Our analysis sees a tactical bounce: price ~313 still 14-15pts below 50-day 327.42 and 200-day 328.06 with daily falling 50-day, but tactical bounce intact off 277.77 washout (+11.5% to 309.84) above 10-EMA 303.83 and mid band 310.77, MACD -9.02 with histogram +0.79 flip, RSI 37.45 to 49.5. Fundamentals: revenue 2.89B to 4.69B +62.4% operating driven, op income +60.7%, EPS 3.17 vs 1.82, OCF 410M vs 152M, TTM FCF 729M, net debt 561M to 274M, retained earnings positive, ROE 52%, forward PE 16 PEG 1.0 target 477 (+52%) 34% off 474 high, but tight: receivables 3.34B + inventory 3.4B (2.7B raw) on 537M cash, current 1.22, capex 263M vs 32M, Q2 FCF 147M, payables +1,025M funding, guidance only maintained conditioned on hyperscaler capex/tariffs/CCS/capacity. Sentiment is 13-0 bullish on Broadcom networking +2.5x and OpenAI Jalapeno 2027-2028 with Broadcom/Celestica, vs neutral options with P/C 0.93 and IV 59.6% and a market fear gauge at 42.1 plus high yields. Risks include death cross lean, failed mid August histogram (+1.82 to -3.47), 30-pt ranges, 371 to 314 -15% on 8.7M shares, payables quality, P/B 14.5, unanimous bullish fade risk, -5.62% valuation fade after +12% Broadcom spike. Our analysis views 327.42 vs 328.06 only 0.64 apart with flat 200-day as coiled short cover trigger the crowd targets, not entrenched distribution; trajectory OCF surge, deleveraging, PPE 1.179B as EMS operating leverage ramping hyperscaler programs, PEG 1.0 priced expansion not euphoria; trough momentum (RSI room to 60, 10-EMA up 300 to 303.83, ATR compressing from 29) plus washout hold outweighs overhead for ATR sized trader. Discipline is staged: starter not full counter trend position, no add into 327-328 supply, require second histogram bar/RSI>50/volume close >328. This supports a directional Buy for 5-day alpha on reclaim attempt.

What would weaken it

  • Death cross lean, wide ranges with overhead at 327-328 supply
  • Tight liquidity: high receivables/inventory, payables-funded cash
  • Hyperscaler capex, tariff/CCS cut; -5.62% fade after +12% spike

This case is at least 12 trading days old. The current day’s signals are for members.